Intestinal phase-II metabolism of quercetin in HT29 cells, 3D human intestinal tissues and in healthy volunteers : a qualitative comparison using LC-IMS-MS and LC-HRMS

Flavonoids are a large class of dietary molecules, among which quercetin is the most ubiquitous, which undergo an extensive intestinal phase-II metabolism. We compared the in vivo metabolism of quercetin in healthy volunteers with two in vitro models, HT29 cells and 3 D human intestinal tissues. Supernatants of the in vitro experiments and the human intestinal fluids (HIF) were analyzed by LC-IMS-MS and LC-HRMS in a qualitative way. Quercetin glucuronides, sulfates and their methyl conjugates were detected in all three systems. The metabolic profiles were found to be different, both in terms of the metabolites produced and their relative proportions. In particular, quercetin sulfates were almost absent in supernatants from HT29 cells incubations while they were a major metabolite in HIF and also found in 3 D intestinal tissues incubations. IMS provided structural information as well as a third dimension of characterization, while HRMS brought increased sensitivity and MS/MS confirmation. HT29 cells are a useful tool to generate phase-II metabolites but do not represent the in vivo situation. 3 D intestinal tissues appear as a more relevant tool to study the intestinal phase-II metabolism of flavonoids.

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:49

Enthalten in:

Xenobiotica; the fate of foreign compounds in biological systems - 49(2019), 8 vom: 20. Aug., Seite 945-952

Sprache:

Englisch

Beteiligte Personen:

Chalet, Clément [VerfasserIn]
Hollebrands, Boudewijn [VerfasserIn]
Duchateau, Guus S [VerfasserIn]
Augustijns, Patrick [VerfasserIn]

Links:

Volltext

Themen:

3D model
9IKM0I5T1E
Clinical Trial
Comparative Study
Glucuronides
Hrms
In vitro/in vivo correlation
Intestinal metabolism
Ion-mobility
Journal Article
Lc-ms
Quercetin

Anmerkungen:

Date Completed 23.12.2019

Date Revised 23.12.2019

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1080/00498254.2018.1509246

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM28725142X